DrugDashboards

Colchicine

Colchicine · COLCHICINE .6 mg/1 · Capsule · Oral · American Health Packaging

NDC 60687-0358-25 · 30 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 CAPSULE in 1 BLISTER PACK · NDA · View full market →

The short version

12 companies supply this market — deep enough that no single failure threatens the supply. The brand price has fallen 40% in a year, to $1.88 per unit — and generics that get this cheap tend to get abandoned rather than defended. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$1.88per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$1.13per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal ceiling (Big4)$97.25per package of 5X6Amerisource Health Services LLC dba American Health Packaging · Jan 1, 2026
  • Medicaid generic ceiling (FUL)$1.91per CAPweighted avg manufacturer price $1.0935 · Aug 1, 2026102% of what pharmacies pay — higher than 57% of drugs with this benchmark

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00254-0460-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$3.24per unit
middle half $1.61$3.62 · 816 plans · Apr 1, 2026
Est. net of rebates
$1.94–$2.43
brand drug — est. 25-40% rebate off the price at left
Coverage & restrictions
15%of plans cover it
tier 4 · prior auth 0% · step therapy 0% · qty limit 59%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

$0$2.00$4.00$6.00Aug 2018Sep 2026$1.88
98 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$56.29
#90 count
$168.86

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2024)

$4,665
23 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

15Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 40% year over year+15

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for colchicine (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA204820
TE code
AB
Approval date
Sep 26, 2014
Patents / exclusivity
5 patents, 0 exclusivities
TypeNumber / codeExpires
patent9555029Aug 22, 2033
patent9789108Aug 22, 2033
patent9675613Aug 22, 2033
patent8927607Aug 22, 2033
patent9399036Aug 22, 2033

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Colchicine (Capsule)

LabelerStrengthFirst seenLast seen
Coupler LLCCOLCHICINE .6 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsCOLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCOLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackCOLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.COLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
Granules Pharmaceutical Inc.COLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.COLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
Hikma Specialty USA Inc.COLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsCOLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
Micro Labs LimitedCOLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
Par Health USA, LLCCOLCHICINE .6 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedCOLCHICINE .6 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Colchicine — NDC 60687-0358-25," retrieved September 3, 2026, https://drugdashboards.com/drug/60687035825.

Free to cite with attribution — see how the data is put together.